华仁药业
(300110)
| 流通市值：34.14亿 | | | 总市值：34.17亿 |
| 流通股本：11.81亿 | | | 总股本：11.82亿 |
| 报告期 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 309,965,165.17 | 1,321,454,092.38 | 976,270,444.55 | 623,896,434.45 |
| 营业收入 | 309,965,165.17 | 1,321,454,092.38 | 976,270,444.55 | 623,896,434.45 |
| 二、营业总成本 | 289,559,960.82 | 1,204,460,892.77 | 908,109,518.39 | 580,297,334.96 |
| 营业成本 | 206,903,941.21 | 831,915,880.14 | 642,895,832.33 | 388,481,128.59 |
| 税金及附加 | 5,534,190.7 | 21,663,256.87 | 15,891,847.19 | 10,593,727.41 |
| 销售费用 | 30,631,620.5 | 150,362,677.61 | 101,306,237.93 | 83,111,639.18 |
| 管理费用 | 22,786,352.76 | 90,393,682.15 | 65,861,447.72 | 44,679,018.12 |
| 研发费用 | 14,080,034.45 | 67,825,661.63 | 48,370,181.95 | 29,961,200.24 |
| 财务费用 | 9,623,821.2 | 42,299,734.37 | 33,783,971.27 | 23,470,621.42 |
| 其中:利息费用 | 9,356,759.36 | 41,969,585.59 | 31,590,965.01 | 21,235,172.89 |
| 其中:利息收入 | 53,030.79 | 523,301.92 | 287,103.27 | 239,406.96 |
| 三、其他经营收益 | | | | |
| 加:投资收益 | -44,283.19 | 4,815,796.52 | 2,281,821.8 | 2,298,173.26 |
| 资产处置收益 | 0 | 7,332.49 | 0 | 0 |
| 资产减值损失(新) | 9,557.52 | -563,219,531.8 | -1,112,415.07 | -1,112,415.07 |
| 信用减值损失(新) | 546,574.58 | -22,904,890.73 | -13,968,652.22 | -10,469,832.22 |
| 其他收益 | 1,989,472.94 | 8,612,828.1 | 7,322,078.12 | 7,523,266.03 |
| 四、营业利润 | 22,906,526.2 | -455,695,265.81 | 62,683,758.79 | 41,838,291.49 |
| 加:营业外收入 | 46,753.14 | 2,568,119.11 | 2,180,154.49 | 2,149,924.94 |
| 减:营业外支出 | 2,873,983.48 | 5,814,169.1 | 1,585,943.86 | 1,140,657.34 |
| 五、利润总额 | 20,079,295.86 | -458,941,315.8 | 63,277,969.42 | 42,847,559.09 |
| 减:所得税费用 | 3,275,886.86 | 447,760 | 5,879,952.99 | 3,682,578.47 |
| 六、净利润 | 16,803,409 | -459,389,075.8 | 57,398,016.43 | 39,164,980.62 |
| (一)按经营持续性分类 | | | | |
| 持续经营净利润 | 16,803,409 | -459,389,075.8 | 57,398,016.43 | 39,164,980.62 |
| (二)按所有权归属分类 | | | | |
| 归属于母公司股东的净利润 | 15,958,601.73 | -462,900,017.63 | 54,579,793.85 | 37,332,883.17 |
| 少数股东损益 | 844,807.27 | 3,510,941.83 | 2,818,222.58 | 1,832,097.45 |
| 扣除非经常损益后的净利润 | 16,512,325.85 | -470,281,564.11 | 45,727,165.65 | 27,689,155.59 |
| 七、每股收益 | | | | |
| (一)基本每股收益 | 0.01 | -0.39 | 0.05 | 0.03 |
| (二)稀释每股收益 | 0.01 | -0.39 | 0.05 | 0.03 |
| 九、综合收益总额 | 16,803,409 | -459,389,075.8 | 57,398,016.43 | 39,164,980.62 |
| 归属于母公司股东的综合收益总额 | 15,958,601.73 | -462,900,017.63 | 54,579,793.85 | 37,332,883.17 |
| 归属于少数股东的综合收益总额 | 844,807.27 | 3,510,941.83 | 2,818,222.58 | 1,832,097.45 |
| 公告日期 | 2026-04-24 | 2026-04-24 | 2025-10-30 | 2025-08-16 |
| 审计意见(境内) | | 标准无保留意见 | | |